BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 24461517)

  • 1. Antagonism of microRNA-99a promotes cell invasion and down-regulates E-cadherin expression in pancreatic cancer cells by regulating mammalian target of rapamycin.
    Li D; Li X; Cao W; Qi Y; Yang X
    Acta Histochem; 2014 Jun; 116(5):723-9. PubMed ID: 24461517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of microRNA 99a in oral squamous cell carcinomas contributes to the growth and survival of oral cancer cells.
    Yan B; Fu Q; Lai L; Tao X; Fei Y; Shen J; Chen Z; Wang Q
    Mol Med Rep; 2012 Sep; 6(3):675-81. PubMed ID: 22751686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-451 regulates AMPK/mTORC1 signaling and fascin1 expression in HT-29 colorectal cancer.
    Chen MB; Wei MX; Han JY; Wu XY; Li C; Wang J; Shen W; Lu PH
    Cell Signal; 2014 Jan; 26(1):102-9. PubMed ID: 23899558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Protocadherin 10 (PCDH10) inhibits the proliferation, invasion and migration ability of BXPC-3 pancreatic cancer cells].
    Qiu C; Bu X; Hu D; Jiang Z
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Feb; 32(2):163-7. PubMed ID: 26927373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of KL-6/MUC1 in pancreatic cancer tissues and its potential involvement in tumor metastasis.
    Xu H; Inagaki Y; Seyama Y; Du G; Wang F; Kokudo N; Tang W
    Oncol Rep; 2011 Aug; 26(2):371-6. PubMed ID: 21617869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-99a inhibits insulin-induced proliferation, migration, dedifferentiation, and rapamycin resistance of vascular smooth muscle cells by inhibiting insulin-like growth factor-1 receptor and mammalian target of rapamycin.
    Zhang ZW; Guo RW; Lv JL; Wang XM; Ye JS; Lu NH; Liang X; Yang LX
    Biochem Biophys Res Commun; 2017 Apr; 486(2):414-422. PubMed ID: 28315335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-mediated downregulation of mTOR/FGFR3 controls tumor growth induced by Src-related oncogenic pathways.
    Oneyama C; Ikeda J; Okuzaki D; Suzuki K; Kanou T; Shintani Y; Morii E; Okumura M; Aozasa K; Okada M
    Oncogene; 2011 Aug; 30(32):3489-501. PubMed ID: 21383697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-99a promotes proliferation targeting FGFR3 in human epithelial ovarian cancer cells.
    Jiang H; Qu L; Wang Y; Cong J; Wang W; Yang X
    Biomed Pharmacother; 2014 Mar; 68(2):163-9. PubMed ID: 24456664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockdown of long non-coding RNA ANRIL inhibits tumorigenesis in human gastric cancer cells via microRNA-99a-mediated down-regulation of BMI1.
    Liu P; Zhang M; Niu Q; Zhang F; Yang Y; Jiang X
    Braz J Med Biol Res; 2018 Aug; 51(10):e6839. PubMed ID: 30156609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of epithelial and mesenchymal proteins in a panel of prostate cancer cell lines.
    Murali AK; Norris JS
    J Urol; 2012 Aug; 188(2):632-8. PubMed ID: 22704442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulating ribonuclease inhibitor enhances metastasis of bladder cancer cells through regulating epithelial-mesenchymal transition and ILK signaling pathway.
    Xiong D; Liou Y; Shu J; Li D; Zhang L; Chen J
    Exp Mol Pathol; 2014 Jun; 96(3):411-21. PubMed ID: 24768914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SOX2 promotes the migration and invasion of laryngeal cancer cells by induction of MMP-2 via the PI3K/Akt/mTOR pathway.
    Yang N; Hui L; Wang Y; Yang H; Jiang X
    Oncol Rep; 2014 Jun; 31(6):2651-9. PubMed ID: 24700142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of NCAPG by miR-99a-3p (passenger strand) inhibits cancer cell aggressiveness and is involved in CRPC.
    Arai T; Okato A; Yamada Y; Sugawara S; Kurozumi A; Kojima S; Yamazaki K; Naya Y; Ichikawa T; Seki N
    Cancer Med; 2018 May; 7(5):1988-2002. PubMed ID: 29608247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-99a and -99b inhibit cervical cancer cell proliferation and invasion by targeting mTOR signaling pathway.
    Wang L; Chang L; Li Z; Gao Q; Cai D; Tian Y; Zeng L; Li M
    Med Oncol; 2014 May; 31(5):934. PubMed ID: 24668416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Both inhibition and enhanced expression of miR-31 lead to reduced migration and invasion of pancreatic cancer cells.
    Laurila EM; Sandström S; Rantanen LM; Autio R; Kallioniemi A
    Genes Chromosomes Cancer; 2012 Jun; 51(6):557-68. PubMed ID: 22344632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short hairpin RNA targeting FOXQ1 inhibits invasion and metastasis via the reversal of epithelial-mesenchymal transition in bladder cancer.
    Zhu Z; Zhu Z; Pang Z; Xing Y; Wan F; Lan D; Wang H
    Int J Oncol; 2013 Apr; 42(4):1271-8. PubMed ID: 23403865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of miRNA-143 and the non-coding RNA MALAT1 on the pathogenesis and metastasis of HeLa cells.
    Zhang L; Niyazi HE; Zhao HR; Cao XP; Abudula MN; Ye WJ; Zhang SA; Yiming RH; Zhang Y; Su WP; Chen R; Ouyang Y; Miao N; Bao YX
    Genet Mol Res; 2017 Feb; 16(1):. PubMed ID: 28252165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-145 suppresses cell proliferation, invasion and migration in pancreatic cancer cells by targeting NEDD9.
    Han T; Yi XP; Liu B; Ke MJ; Li YX
    Mol Med Rep; 2015 Jun; 11(6):4115-20. PubMed ID: 25646678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-218 inhibits cell migration and invasion in renal cell carcinoma through targeting caveolin-2 involved in focal adhesion pathway.
    Yamasaki T; Seki N; Yoshino H; Itesako T; Hidaka H; Yamada Y; Tatarano S; Yonezawa T; Kinoshita T; Nakagawa M; Enokida H
    J Urol; 2013 Sep; 190(3):1059-68. PubMed ID: 23454155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The PI3K/Akt/mTOR signaling pathway mediates insulin-like growth factor 1-induced E-cadherin down-regulation and cell proliferation in ovarian cancer cells.
    Lau MT; Leung PC
    Cancer Lett; 2012 Dec; 326(2):191-8. PubMed ID: 22922215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.